Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor γ

Journal of Immunology

Volumn 169, Issue 3, 2002, Pages 1228-1235

  Nencioni, Alessio ^a   Grünebach, Frank ^a   Zobywlaski, Anke ^a   Denzlinger, Claudio ^a   Brugger, Wolfram ^a   Brossart, Peter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE;

EID: 0036681640     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.3.1228     Document Type: Article

References (53)

1. Dendritic cells and the control of immunity
2. Immunobiology of dendritic cells
3. Cross-presentation, dendritic cells, tolerance and immunity
4. Constitutive class I-restricted exogenous presentation of self antigens in vivo
5. The induction of tolerance by dendritic cells that have captured apoptotic cells
6. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
7. + T cells
8. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
9. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
10. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
11. PPAR-γ is required for placental, cardiac, and adipose tissue development
12. The peroxisome proliferator-activated receptors: Ligands and activators
13. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
14. 2 is a ligand for the adipocyte determination factor PPAR-γ
15. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor γ ligands and agoinsts
16. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor-γ(PPAR-γ)
17. The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones
18. Isolation of the human peroxisome proliferator activated receptor γ cDNA: Expression in hematopoietic cells and chromosomal mapping
19. Inducible cyclooxygenase may have anti-inflammatory properties
20. Cyclopentenone prostaglandins: New allies in the war on inflammation
21. The peroxisome proliferator-acrivated receptor-γ is a negative regulator of macrophage activation
22. 2 and troglitazone: Evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression
23. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
24. Regulation of inurinc macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-γ: Counter-regulatory activity by IFN-γ
25. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages
26. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
27. Ligands for peroxisome proliferator-activated receptors α and γ inhibit chemically induced colitis and formation of aberrant crypt loci in rats
28. Activation of human T lymphocytes is inhibited by peroxi some proliferator-activated receptor γ (PPARγ) agonists
29. The nuclear receptor PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses
30. The nuclear receptor PPARγ is expressed by mouse T lymphocytes and PPARγ agonists induce apoptosis
31. Peroxisome proliferator-activated receptor-γ activators inhibit interleukin-12 production in murine dendritic cells
32. Peroxisome proliferator-activated receptor γ activators affect the maturation of human monocyte-derived dendritic cells
33. Tumor necrosis factor α and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells
34. Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide
35. A polymcrasc chain reaction-based semiquan titative assessment of malignant melanoma cells in peripheral blood
36. PPAR-γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL
37. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
38. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family
39. Differential expression of Rel/NF-κB and octamer is a hallmark of the generation and maturation of dendritic cells
40. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of NF-κB activation in hemopoietic progenitor cells
41. Differential expression of the transcription factor NF-κB during human mononuclear phagocyte differentiation to macrophages and dendritic cells
42. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
43. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages
44. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
45. GM-CSF and TNFα cooperate in the generation of dendritic Langerhans cells
46. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocytemacrophage colony-stimulating factor
47. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
48. Cyclopentenone protaglandins: New insights on biological activities and cellular targets
49. Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells
50. Cutting edge: Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes
51. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB
52. 2 formation and characterization of its synthetases in various tissues of adult rats
53. 2 is likely APCs